Hypothalamic Sirt1 protein levels increase during feeding, and the forced expression of wild-type Sirt1 in the mediobasal hypothalamus suppresses FoxO1-induced hyperphagia
Sitagliptin was the pioneering agent, followed by linagliptin, vildagliptin, saxagliptin, alogliptin, anagliptin, gemigliptin, and teneligliptin
La presentacin en polvo permite una dosificacin precisa y ajustable segn las necesidades individuales
Genes can also inhibit a patients ability to detox
For type 2 diabetes, usual subcutaneous dosing schedules include starting at 0.25 mg/week, then increasing to 0.5 mg/week, possibly up to 1.0 mg/week or more depending on indication
But going in with realistic expectations about side effects is important